International Clinical Trial: Research on the Optimization of Clinical Rational Drug Use Management Countermeasures of Edaravone and Rilmenidine Based on the Orientation of Medical Insurance Policies

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122551) titled 'Research on the Optimization of Clinical Rational Drug Use Management Countermeasures of Edaravone and Rilmenidine Based on the Orientation of Medical Insurance Policies' on April 15.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Meishan City People's Hospital

Condition: Acute ischemic stroke

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-15

Target Sample Size: Observation group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=303094

Published by HT Digital Content Services with ...